Does botulinum toxin affect psycho-social aspects in dystonia?
Journal of Neural Transmission · 2024-08 · 131 (8) · 953-960
DOI: 10.1007/s00702-024-02785-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neural Transmission, online erschienen am 04.06.2024. Verfasst von Angelica Marfoli und 14 weiteren Autor:innen. Beteiligte Einrichtung: University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Depression, Dystonic Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Milano.
Abstract (Originalsprache)
Dystonia is a movement disorder in which sustained muscle contractions give rise to abnormal postures or involuntary movements. It is a disabling and disfiguring disorder that affects activities of daily living and gives people a bizarre appearance often associated with psychological morbidity, embarrassment and social avoidance. Intramuscular injection of botulinum toxin (BoNT) is the most effective treatment for motor symptoms in focal dystonia, but little is known about its impact on the psycho-social dimension. The main aim of this study was to evaluate psycho-social changes in patients with focal dystonia after starting BoNT treatment using self-reported scales. The Beck Depression Inventory (BDI-II), the 36-Item Short Form Health Survey (SF-36), the Body Uneasiness Test (BUT), the State-Trait Anxiety Inventory (STAI) and the Visual Analogue Scale (VAS) assessing body self-image, satisfaction with physical aspects, social avoidance, self-reported depression, and self-distress were completed by 11 patients with dystonia and 9 patients with hyperhidrosis as a control group before BoNT (T0). VAS was then performed after four weeks (T1) to assess whether BoNT induced changes in the psychosocial dimension. Our results showed that only depressive symptoms and rumination about body defects improved in patients with dystonia after BoNT treatment, while improvement in self-distress and satisfaction with physical aspects was also found in hyperhidrosis. Individuals with hyperhidrosis experience poorer psychological well-being and suffer from higher levels of distress compared to dystonic patients. This suggests that individuals with this disabling condition are more vulnerable to social impact than dystonic patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Milan, Milan, Italy.
- Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- IRCCS Istituto Auxologico Italiano, Milan, Italy.
- Catholic University of the Sacred Heart, Rome, Italy.
- Luigi Vanvitelli University of Campania, Caserta, Italy.
- ASST Santi Paolo e Carlo, University Research Centre Aldo Ravelli, Milan, Italy.
ORCID-Profile: Roberta Ferrucci
Förderung
- Università degli Studi di Milano
Zitieren
APA
Marfoli, A., Mameli, F., Aiello, E. N., Ruggiero, F., Sandi, A., Mellace, D., Curti, B., Vimercati, R., Poletti, B., Ticozzi, N., Chieffo, D., Santangelo, G., Barbieri, S., Priori, A., & Ferrucci, R. (2024). Does botulinum toxin affect psycho-social aspects in dystonia?. Journal of Neural Transmission, 131(8), 953-960. https://doi.org/10.1007/s00702-024-02785-z
Vancouver
Marfoli A, Mameli F, Aiello EN, Ruggiero F, Sandi A, Mellace D, et al. Does botulinum toxin affect psycho-social aspects in dystonia?. Journal of Neural Transmission. 2024;131(8):953-960. doi:10.1007/s00702-024-02785-z
BibTeX
@article{Marfoli2024,
author = {Marfoli, Angelica and Mameli, Francesca and Aiello, Edoardo Nicolò and Ruggiero, Fabiana and Sandi, Angelica De and Mellace, Denise and Curti, Beatrice and Vimercati, Roberto and Poletti, Barbara and Ticozzi, Nicola and Chieffo, Daniela and Santangelo, Gabriella and Barbieri, Sergio and Priori, Alberto and Ferrucci, Roberta},
title = {Does botulinum toxin affect psycho-social aspects in dystonia?},
journal = {Journal of Neural Transmission},
year = {2024},
volume = {131},
number = {8},
pages = {953--960},
doi = {10.1007/s00702-024-02785-z}
}
EUVIMED